26 June 2011

Director’s Cut -- Service as usual will resume shortly :: Macquarie Research

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Director’s Cut
Service as usual will resume shortly
Two separate items point strongly to the belief that the second half should see
an uptick in the confidence of growth across the globe.
In an article in today’s FT, China’s premier Wen Jiabao declares the inflation
dragon has been slayed.  “China has made capping price rises the priority of
macroeconomic regulation and introduced a host of targeted policies. These
have worked. The overall price level is within a controllable range and is
expected to drop steadily.”  As well as “… growth in money and credit supply has
returned to normal”. This is important, as it is a very public airing of the view that
China has done enough to bring about a soft landing. As Paul Cavey has been
noting for some time, the PMI has been steadily falling back toward 50, showing
the slowdown in manufacturing expansion and the only shoe left to drop was the
stubbornly high inflation statistics. Inflation has now been declared dead and pity
any far-flung data collector who tries to send evidence to the contrary. So now
that the PBOC has done enough to effect the slowing, the next phase is the
market’s mindset changing to how soon the easing could come.
Second is oil. For only the third time in 37 years, the IEA has decided to release
oil, intervening in the natural state of markets to find an equilibrium. The official
reason is the lack of supply response to the oil lost in Libya, approximately 1.6 m
b/d. Whilst some members of OPEC are to increase production to meet this
shortfall, not all members could agree, so the IEA is to release 60m barrels over
the next 30 days. That said, the real threat of shortage is in light sweet crude,
which Libya was a large supplier of but of which the rest of OPEC are not a good
source – hence a need to balance this market with light sweet crude from the
strategic reserves. The decision to release can effectively be seen as addressing
the four Gs – gap, grade and getting there fast, which are all aimed at causing
the 4
th
G; growth. Light sweet is the best input for gasoline and hence in great
demand in industrialised countries. The important point is the move to release
under these circumstances is unprecedented – hence the market will take it as a
sign that the IEA is prepared to use reserves to prevent a blow out in oil prices
hindering the slow grinding recoveries in the developed world. So, following this
logic, oil upside is capped and the recovery is to be rewarded with support in the
form of greater oil price certainty.
Whilst the overall position in WTI oil is net short, the really interesting feature is
the retail market is at a peak long, offset by a bearish commercial market.
Weakness in Oil ETFs is likely as retail speculators move out of these products.
Prospects of improving growth (China item) and an implicit subsidy in oil will
benefit the transport sector, with FedEx and airlines the clearest beneficiaries.

Macquarie Research, Director’s Cut -- Survival of the fittest in smartphones

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Director’s Cut
Survival of the fittest in smartphones
Mobiles are clearly a tough business where only the fittest survive and thrive.
Despite this, given the trend towards mobility and the exponential growth
expected in smartphones and mobiles, it’s still a sector that’s very attractive.
Research in Motion (RIMM US) is the latest company to feel the competitive
pressure, with the stock down about 60% from the February high. But Kevin
Smithen thinks RIMM is compelling value and has initiated coverage with an
Outperform. He admits RIMM’s US market share is falling but says sales outside
North America are both larger and growing at a faster rate. Kevin also likes
RIMM’s high margin services and software annuity, which underpins earnings
and cash flows. There could also be some positive surprise from PlayBook, with
the market ascribing no value to RIMM’s tablet. Last but not least, Kevin’s
forecast TSR of over 40% is also attractive.  >> Read Report
Samsung Electronics (005930 KS) is another key winner from the shift to
mobile, with Daniel Kim expecting the Galaxy S II to be an even bigger hit than
its previous model. Keep in mind, Apple’s next gen iPhone is not expected to be
released until the fourth quarter, while there are no serious challengers in the
Android camp. In this light, the new Galaxy faces benign competition in the highend smartphone segment for the rest of 2011. From current prices, there is also
more than 40% upside in Samsung Electronics.  >> Read Report on Galaxy S II


Highlights
 Jim Lennon sees a strong rebound in China’s metal demand in the second
half, and that easing credit could prompt restocking.
 Gary Pinge continues to believe the market is mispricing Li & Fung (494
HK), expecting higher than achievable organic growth.
 Adrian Wood says his top pick in the ASX listed LNG space is Oil Search
(OSH), with exploration upside supporting his bullish view.

Macquarie Research, Director’s Cut -- Survival of the fittest in smartphones

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Director’s Cut
Survival of the fittest in smartphones
Mobiles are clearly a tough business where only the fittest survive and thrive.
Despite this, given the trend towards mobility and the exponential growth
expected in smartphones and mobiles, it’s still a sector that’s very attractive.
Research in Motion (RIMM US) is the latest company to feel the competitive
pressure, with the stock down about 60% from the February high. But Kevin
Smithen thinks RIMM is compelling value and has initiated coverage with an
Outperform. He admits RIMM’s US market share is falling but says sales outside
North America are both larger and growing at a faster rate. Kevin also likes
RIMM’s high margin services and software annuity, which underpins earnings
and cash flows. There could also be some positive surprise from PlayBook, with
the market ascribing no value to RIMM’s tablet. Last but not least, Kevin’s
forecast TSR of over 40% is also attractive.  >> Read Report
Samsung Electronics (005930 KS) is another key winner from the shift to
mobile, with Daniel Kim expecting the Galaxy S II to be an even bigger hit than
its previous model. Keep in mind, Apple’s next gen iPhone is not expected to be
released until the fourth quarter, while there are no serious challengers in the
Android camp. In this light, the new Galaxy faces benign competition in the highend smartphone segment for the rest of 2011. From current prices, there is also
more than 40% upside in Samsung Electronics.  >> Read Report on Galaxy S II

India Steel -Analyzing steel export-import data highlights no easy way out from FLATS over capacity:: JPMorgan

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


India Steel
Analyzing steel export-import data highlights no easy
way out from FLATS over capacity


 Entering surplus zone, particularly in flat steel: In our view India has entered
a  period  of  over capacity in  steel, with the capacity impact to  be  felt  over the
next few quarters. Capacity additions of c.5MT in longs and c.16MT in flats is
expected by mid CY12E, when FY11 consumption stood at 31MT in longs and
33MT in  flats implying  far larger  capacity  build  out in  flats.  This  comes  at a
time of weakening demand. This has led to expectations of import substitution
in flats as well as increasing exports (India was a net exporter in April)
 India’s  flat  steel  imports- A  combination  of price  sensitive imports  and
higher grades: Flat steel accounted for 91% of  India's 5.9MT imports. Of this,
Plates  (13%),  HR  Coils  (39%)  and  CR  (19%)  account  for  a  large  part  of  the
gross imports. Analyzing the country and  value wide  data, imports  from  Japan
and  Korea  are  at  significant  premium to  import/mt  values  from  Russia/China,
implying imports from Korea/Japan are essentially value added steel and hence
not  likely  substitutable  from  the  domestic  market.  Imports  from  these
countries (which are steel plates, HR/CR) stood at c.1.5MT (~25% of FY11
imports) and in our view for a large part are not substitutable.
 The  remaining  IS  substitutable,  but  would  require  domestic  prices  to
MOVE to a SIGNIFICANT DISCOUNT: We estimate 'commodity grade’ flat
steel  imports  in  FY11  stood  at  c.4MT  (mainly  in  HR  and  CR).  However  we
believe that replacing this would not be easy, as a large part of these imports, in
our  view  are  driven  by  pricing  arbitrage  (domestic  v/s  imported  prices)  and
would need  domestic  prices to remain  significantly  below imported  prices. We
maintain  our  view that  domestic  HRC  prices  need to  move towards EXPORT
PARITY  model  v/s  previously  IMPORT  PARITY.  The  difference  as  per  our
calculations is  $60-80/MT  on  commodity  grades.  Higher  import  tariffs  would
obviously be a positive.
 But can companies export out their over capacity “profitably”? Not so easy
in  our  view:  Import  substitution  can take  place  via lower  prices  (and this  has
happened over the last few months in our view), but it would not be enough in a
period  of  weak  domestic  demand.  Exports  have  increased  over  the  last  few
months.  However, given  globally  we  are in an  era  of  surplus  capacity in  most
markets  and  regions,  sustained  high  level  of  exports  are  difficult.  As  of  now
exports are less profitable than domestic sales in our  view even after including
the Rs850-900 (~$20/MT) DEPB benefits. Given the Chinese over capacity, we
believe sustained high level of exports out of India are not likely
 From a net importer to a net exporter can provide 4-5MT of additional demand
for Indian flat steel producers (~25% of new capacity) but we do not expect this
to be an easy and likely lower margin.


GlaxoSmithKline Pharma: Book Profits :: Business Line

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Shareholders can consider booking profits in the stock of GlaxoSmithKline Pharma (GSK Pharma).
At Rs 2,331, the stock trades at about 30 times its likely CY11 per share earnings, at a huge premium to large-cap peers. Though the company has always enjoyed premium valuations, driven by its strong balance sheet, high cash reserves (about Rs 1,948 crore, which equals cash per share of Rs 230) and attractive product portfolio, its present valuations leave little room for the stock price to appreciate.
This calls for at least a partial profit-booking by shareholders, especially those with a low-risk appetite. Absence of any significant revenue triggers in the near term and likelihood of margin pressure given the turnaround time for the newly added sales force to improve productivity could also keep the stock price capped.

STRONG FUNDAMENTALS

An entrenched domestic market presence, deep pockets to penetrate the Indian markets and access to products from its parent's stable make GSK Pharma a unique play. It enjoys a strong position in most of the categories in which its products are sold.
For instance, its acute care classic brands such as Calpol, Phexin, Cetzine, Neosporin, Cobadex CZS and Zyloric boasted growth rates better than the market in 2010. Rotarix, the rota-viral diarrhoea vaccine; Tykerb, the breast cancer drug; and Cervarix, the first vaccine with a potential to prevent select strains of cervical cancer, too have done well in the year gone by.
Cervarix is the market leader in HPV vaccines segment as per IMS Sep 2010 audit. Last year Rotarix crossed the Rs 50-crore sales mark. As a result, GSK now enjoys a leadership position in the vaccines segment, with a 19.86 per cent share (as per MAT 12/2010).
GSK Pharma has strengthened its presence in the dermatology segment, helped by its parent's acquisition of the US-based dermatology company, Stiefel Laboratories, globally. The management has said that itss Stiefel-promoted range of products have started making visible progress. The segment recorded growth well ahead of the market growth in 2010, with GSK's key therapies — topical antibiotics, antifungal, emollients, sunscreen and acne — registering strong performance.
GSK enjoys a position of strength in the hospital and tender business. For the quarter ended December 2010, the company enjoyed a market share of 6.25 per cent, top slot, in the hospital segment as per IMS Hospital Audit.

NEW PRODUCTS

Product launches have helped the company add to growth opportunities. While some of the high-profile product launches of earlier years – Rotarix, Tykerb and Cervarix – have done well and hold immense growth potential, other launches such as Mycamine — which was in-licensed from Astellas, Parit D capsules and the re-launched Cefspan — have also met with good success. Revenues from new products made up over 7 per cent of the top line last year (CY10).
For the coming years, GSK has lined up a number of products from the branded generics space and from its parent's folio for launch in India. It has already received marketing approvals for Revolade and Votrient in the March 2011 quarter. Pneumococcal vaccine Synflorix, high-end antibiotics through in-licensing arrangements with other companies and branded generics in the cardiac and central nervous system segments, and speciality products in dermatology are among the other products lined-up for the year. With the company now open to differential pricing to suit the local market's dynamics, product launches can be expected to see decent demand.
The last few years have seen pharma companies — local and MNCs — aggressively add to their field force. GSK too had increased its field strength to about 2,900 agents by end of 2010. While the number doesn't compare favourably over some of the domestic peers, a strong product folio and the company's differentiated product strategy, with a focus on rural markets for mass therapies and on urban markets for chronic diseases, make it a strong contender.
GSK had in early 2011 said that it would add 500-600 sales personnel over the year. It has added over 550 sales agents in the first quarter itself. That said, it may take a while before the benefits from the newly added sales force begin to accrue.

EARNINGS SCORECARD

In the quarter-ended March 2011, the company managed a modest year-on-year sales growth of about 11.4 per cent to Rs 603 crore. The quarter also saw two new product launches — branded generic Calpol-T and Ansolar (Sunscreen Gel) from the Stiefel Dermatology range. However, profits sagged to Rs 46 lakh, driven by higher one-time provisioning – towards a liability in a drug-pricing case for which it has provisioned about Rs 161 crore (the final payout however is subject to the court's judgment).
Prior to exceptional items, profit after tax grew by 16 per cent. Operating margins for the quarter contracted by about two percentage points to 35.7 per cent.

Bata India: Book Profits:: Business Line

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Bata may find it difficult to match earnings growth to valuations.
The stock of Bata India has shot up 41 per cent from January '11 to date, completely bucking broader market trends. The company benefitted from its presence in the evergreen consumption sector, its erstwhile real estate division, and negligible debt.
However, at Rs 528 the stock is at 33 times trailing 12-month earnings (adjusting for one-time income of Rs 109 crore), close to its five-year average PE of 31.7 times.
Bata is making a move to shift from its low-cost value positioning to a mid-market and premium brand. The success of this move may take quite a while to come forth, and the company may face stiff competition from domestic and international brands. Revenues from real estate, which have propped earnings, are set to dry up with the company exiting its real estate joint venture.
These factors pose risks to Bata's ability to match earnings growth to high valuations. Investors may, therefore, book profits in their holdings in the stock and make the most of the scorching run it has had.
Bata India manufactures and retails footwear, with brands such as Marie Claire, Dr. Scholls and Bubblegummers, straddling multiple consumer segments. Relatively newer brands in Bata's fold are premium Hush Puppies and outdoor gear Weinbrenner.
Bata retails through a network of over 1m200 stores across the country. It has ambitious expansion plans in place, aiming to open about 100 large-format stores a year for the next three years. Bankrolling expansion is unlikely to pose a hurdle, given the company's low debt-equity of 0.1 times and its strong cash position (Rs 135 crore cash in hand at end-FY10) .

CHANGING PERCEPTION

Bata commands a strong standing as a low-cost, functional brand at the entry level and as a school-wear brand. However, it is trying to shed this image in favour of a trendier, premium standing, targeted at the vast youth market that is more open to spending more for better quality.
Changing consumer perception, however, is a challenging task and could take a long time. It requires investments in promotion and advertising. The footwear market is crowded with domestic and international brands such as Metro, Woodlands, Puma, Clarks and Reebok; most of which already have a firm footing in the youth market. With international brands looking to Indian markets to augment their revenues, competition in the branded footwear market is likely to further heat up.
Much of the Indian footwear market is fragmented and dominated by the unorganised sector.
In the March '11 quarter, the company received Rs 109.35 crore in consideration for disposing its stake in its real estate joint venture. This one-time income resulted in a six-fold jump in net profits. The company still stands to receive constructed space at no cost, but revenue from real estate ventures is not likely to flow in.
Bata is a turnaround story, utilising its securities premium account to completely write off accumulated losses in 2007. In FY-07 (Jan – Dec '07) the company posted a revenue growth of 12 per cent, a significant jump from the flat revenues in the years before that.
Since then, however, revenue growth has hovered at that level, even as the company shut more unviable stores and revamped others. Revenues have clocked a three-year compounded annual sales growth of 13 per cent to Rs 1,258 crore in FY-10. Net profits have grown 26 per cent to Rs 95 crore in the same period. Operating and net margins during this period have hovered at around 12 and 7 per cent, respectively.
Margins are unlikely to show significant expansion as the streamlining of operations as part of the turnaround strategy — which had earlier boosted margins — is more or less complete. Costs such as promotion and advertising may also rise as the company pushes its brands. Premium product lines such as Hush Puppies do bring in higher margins, but these are nascent segments. Significant margin increases in the near term on account of these lines are not likely

India Strategy - What’s Working, What’s Not: June- Morgan Stanley Research,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Key MoM takeaway on styles:
•  Stocks that are up on a trailing 1M
basis were the worst hit in the past
month. However, on a 12M trailing
basis they continued to be investor
favorites.
•  The market also continued to
reward stocks with rising
institutional ownership.
•  Stocks of companies with poor
fundamentals and high valuations
bore the front of price fall.
•  Over the past 12 months, investors
have been rewarding stocks of
companies with rising institutional
ownership and trailing 12-month
performance. In contrast, high beta,
high leverage, small cap and low
quality (low free cash flow) have
been losing strategies.


What’s Working, What’s Not
•  Key Debate: This is the latest edition of our new
product, which focuses on what styles are generating
returns for investors. We address the question of which
styles have been working over the past year and
month. We also evaluate the differences between
2003-07 and the ongoing bull market in terms of
winning styles (pages 8-9). We filter stocks that have
the most  “overweight” or “underweight” signals based
on styles (page 7).
• What has happened over the past month and
12 months? For long-only fund managers, over the
past month, high beta continued to be a big loser,
whereas high institutional ownership and valuations
appear to be in favor. For hedge funds, in the most
recent month, rising institutional ownership and
valuations are in favor as stock-picking strategies. High
beta and low ROE are losing money for investors.
• Over the past 12 months, investors have been
rewarding stocks of companies with rising institutional
ownership and trailing 12-month performance. In
contrast, high beta, high leverage, small cap and low
quality (low free cash flow) have been losing strategies.
Some of these winning strategies are bit different from
what has worked over the long run (see adjoining text).
•  Our Approach: Our product focuses on assessing which
factors or styles are working and which ones are not. We have
reviewed the performance of 18 most actively used styles and
back-tested their ability to pick stocks (both winners and losers)
in a portfolio context. We calculate factor (investment style)
returns as follows: At the end of each month, we sort the stocks
in our universe on their current exposure to the given style (for
P/E, we sort stocks on P/E as at the end of the month). We
then form a portfolio of stocks using the top and bottom
quintiles and calculate the median returns for each basket
going 12 months forward. We accumulate these returns for
each month by re-sorting at the end of each month, going back
to 1993. This methodology allows us to test the efficacy of a
given style in picking both good and bad stocks. Our 18 factors
include factors from three categories: Fundamentals (quality,
growth and financial leverage), valuations, and market
dynamics (like price momentum, ownership, beta and size).
•  Over the long run, not surprisingly, the market focuses on a
combination of high quality, high growth, cheap valuations, and
small size. Stocks with these characteristics do well over
market cycles. The factors that do not work well in picking
stocks include high consensus ratings, high institutional
ownership levels, and high beta. The market message is mixed
on certain growth and quality metrics, such as free cash flows
and ROE delta, but it certainly likes companies with disciplined
capex. There is a surprising bias for past winners in future
winners – implying that stocks that have done well appear to be
continuing to do well.


For Long-only Portfolios: Factor Rankings in the Most Recent Month
Source: FactSet, Company Data, Morgan Stanley Research
•  Over the long run, long-only portfolio managers should be
picking stocks for their portfolios on the basis of strong growth,
high quality, low valuations, small size (i.e., small and mid-cap),
and high leverage. Price momentum is also a key winning style
– i.e., past winners seem to continue to deliver returns. What
doesn’t work includes the consensus view, institutional
ownership, and beta. The market is also not a fan of too much
change in ROE and one-month trailing price momentum. Then
again, low capex is a favored “quality” metric over free cash
flow. The market does not like companies paying too much
dividend – maybe signaling that it prefers companies plough
back cash for growth. The key valuation metric that works over
time is P/B, and top-line growth is more important than EPS
growth (details on slide 4).
•  Some of these factors have not worked over the past
12 months, notably revenue growth, while the consensus view
and low capex has assumed more importance. Over the past
month, small cap high debt-equity and low free cash flow are
big losers whereas high institutional ownership and momentum
appear to be in favor




Sizzling Stocks: Jain Irrigation Systems, Lanco Infra:: Business Line

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Jain Irrigation Systems (Rs 157)
After touching its 52-week low at Rs 128 on June 20, the stock found support around this level and bounced up. It has surged 11 per cent in the previous week with good volumes. But the stock is currently testing twin resistances at Rs 160, a key medium-term resistance and down also trend-line. An emphatic break out from this resistance in the near future can lift the stock higher to Rs 185 and then to Rs 200. Conversely, downward reversal from Rs 160 can pull the stock down to Rs 145 or to Rs 130 in the short-term.
The stock has been on an intermediate-term downtrend since its August 2010 peak of Rs 264. As long as the stock trades below Rs 210, this intermediate-term downtrend remains in place.
Lanco Infratech (Rs 22.9)
The Lanco Infratech stock’s downtrend accelerated after it nose-dived 23 per cent last week. It had decisively broken through its key long-term support level at Rs 27.5 levels. Since attaining its peak of Rs 73 last October , the stock has been on an intermediate-term downtrend. Medium and short-term trends are also down. The stock’s daily as well as weekly indicators are, however, reaching oversold territory. We don’t rule out a near-term corrective up move in the. The stock can rally to Rs 25 and then to Rs 27.5. Failure to move above Rs 25 will pull the stock down to Rs 20 in the medium-term. Key supports below this level are pegged at Rs 17 and Rs 15.
As long as the stock trades below Rs 35 its short-term trend remains down; only a strong rally above this level will reverse the downtrend

The Great Eastern Shipping Company: Buy:: Business Line

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Investors with a two-year plus perspective can consider buying the shares of The Great Eastern Shipping Company (GESCO), the country's largest private sector shipper.
At its current price of Rs 274, the stock has fallen nearly 30 per cent from its high in November last year, and trades at a steep discount (35 per cent) to its consolidated net asset value.
Its trailing 12-month price-to-earnings ratio (around nine times) is also lower than that of global shipping companies.
Much of this poor show flows from the continued weakness in global shipping freight rates, thanks to an oversupplied market overshadowing improved demand dynamics in both the bulk and tanker categories – a scenario likely to continue for a year or more. This saw GESCO register a 38 per cent decline in profits in the recent March quarter, if one leaves out an impairment charge on sale of vessels.
That said, GESCO's efforts to hedge its business model with an increasing focus towards the high-margin offshore business, and a solid financial position should see it emerge from the turbulence, bruised but still in good fighting shape.
Fairly firm trends in crude oil prices, which provide an incentive for increased exploration activity, bode well for GESCO's offshore business, which is equipped with a modern fleet and commands better rates. This segment in which the company has ambitious expansion plans should help offset, at least to some extent, the weakness in the shipping segment.
In 2010-11, the offshore segment accounted for around a third of the company's revenues but almost 44 per cent of its operating profits. This contribution is set to increase further. Buoyancy in rates has also resulted in margins in the offshore segment improve strongly, from around 24 per cent in 2009-10 to 37 per cent in 2010-11.
Also, freight rates in the currently out-of-favour shipping segment may have bottomed out, given that they are close to average historic lows. Besides, GESCO with its strong financial position (cash balance of more than Rs 1,300 crore and debt-to-equity ratio of around 1) has enough financial muscle to capitalise on further decreases in asset values in the shipping segment.
This will help the company when the cycle turns. GESCO has also been a consistent dividend paying company, with dividend yield of around 3 per cent even in tough years.
The key risk to our recommendation is a major deterioration in the global economy which can keep shipping freight rates depressed longer than expected.

Jain Irrigation:: Will cash flow?:: CLSA

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Will cash flow?
Jain has corrected +35% since Jan-11 on concerns on its burgeoning microirrigation receivables. Our recent interactions suggest, though, that this is starting
to ease with the government sharpening its focus on disbursals. We model a cut in
receivables by 30-days in FY12 but management is more optimistic at 60-70 days;
every 30-day helps EPS by ~2-3%. Meanwhile, micro-irrigation revenue growth
remains resilient at ~30% in 1QFY12. We are cutting our FY12-14 EPS estimates
by 1-3% and our target to Rs225/sh but upgrade our reco to BUY as a rebound in
cashflow should bring focus back on the secular micro irrigation investment theme.
Concerns on cashflow. Jain has corrected +35% from recent peaks largely on
concerns around the burgeoning receivables in the core micro irrigation business which
rose to 372-days by Mar-11 (255 in Mar-09, 316 Mar-10). Part of this is related to the
rising share of average capital subsidies in the overall equipment cost from ~50% as
originally envisaged to ~65% by FY11 as state governments increased their share of
subsidies from 10% to as much as 40% in some cases. This increased the reliance on
government disbursements for overall cashflow and attendant collection delays.
Some reasons. Those disbursements also got delayed in 2010 due to the transition of
micro-irrigation projects to a  mission mode; these involved a change in guidelines,
costing norms and the decision making process. Also, (a) the state elections in Tamil
Nadu (slower bureaucratic decision making), (b) continued political uncertainty in
Andhra Pradesh and (c) sales in Maharashtra being higher than its allocation under the
central government’s scheme (the state was hence short of funds) were also reasons.
Improvements underway. Our recent conversations suggest, though, that this is
starting to ease. We understand, for example, that the central government approved
disbursal of Rs17.6bn in FY12 that should ease the backlog of FY11 (Rs6-7bn) due to
delayed disbursements post the changeover to the mission mode and fund growth in
FY12 (Rs11bn); the state of AP (Rs3bn receivables to Jain) has received part of its
allocation already, for example. In addition, with the elections in Tamil Nadu (Rs2bn)
now over, decision making may quicken here and recoveries could ease. Maharashtra
(Rs4bn) might remain an overhang near term though as allocations still lag subsidies;
this will necessitate the state government drawing funds from other allied schemes.
EPS impact. Management highlighted that it expects gross receivables in microirrigation to stay flat QoQ at Rs17bn implying that incremental sales in 1QFY12 will
match prior recoveries; this implies receivables coming off 22 days QoQ to 351 days.
We model a cut of 30-days by Mar-12 but management is more optimistic hoping for a
cut of 60-70 days; every 30-day cut increases EPS by 2-3% on lower financing costs.
Upgrade to BUY. Meanwhile, micro revenue growth remains resilient at ~30%; we
expect +20%YoY rise in Ebitda in 1Q (+48%YoY reported PAT). We are cutting FY12-14
EPS by 1-3% and our target to Rs225/sh but upgrade our rec to BUY as a rebound in
cashflow should bring focus back on the secular micro irrigation investment theme.

Query Corner: Asian Paints, Edelweiss, Vivimed, LVB, gateway: Business Line

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��



I have purchased shares of Sun Pharma Advanced Research Company at Rs 93. Please let me know the medium and long-term outlook of this stock.
Priyanka Gillon
Sun Pharma Advanced Research Company (Rs 91): This stock continues to be in a structural down-trend since it has retraced only half of the decline recorded in 2008 to date. The long-term outlook will turn positive only on an emphatic weekly close above Rs 130. Such a move will pave the way for a rally towards the stock's previous life-time high at Rs 186.
However, failure to move beyond this resistance will mean that the stock will vacillate in the range between Rs 70 and Rs 130 over the ensuing months. Investors need to start fretting only on a close below Rs 65.
This can also serve as the stop-loss for long-term investors.
The stock will face resistance at Rs 110 and Rs 130 over the medium-term. Investors not in the stock for the long haul can divest their holding at either of these levels. Stop-loss for medium-term investors can be at Rs 78.
I own shares of ITD Cementation. Please let me know the medium and long-term outlook of this share.
MuraliMohan
ITD Cementation India (Rs 153.1): ITD Cementation continues in the throes of a long-term bear market.
The recovery since the first quarter of 2009 stalled around Rs 290, much below the long-term trend decider at Rs 475.
Any rally over the next two years is likely to face strong resistance in the band between Rs 475 and Rs 500. Long-term prospects will turn positive only on a strong close beyond this band.
The stock is currently halting at the key medium-term support around Rs 145.
Investors should divest their holding on a close below this level since that would usher in a fall to Rs 100 or even Rs 70 in the ensuing months.
Conversely, reversal above Rs 145 will take the stock higher to Rs 205 or Rs 240.
I have bought shares of Edelweiss Capital at Rs 62 and Shanthi Gears at Rs 51. Can I sell these shares at current levels?
N. Gopalakrishnan
Edelweiss Capital (Rs 33.9): The trends along all time-frames, long, medium and short are currently down in Edelweiss Capital.
Its long-term view will improve only if the stock goes on to close above Rs 82. Otherwise, the stock could keep moving in a range between Rs 20 and Rs 80.
Key medium-term support for Edelweiss Capital is at Rs 40. Since the stock has closed strongly below this level, it can now go on to slide to Rs 27 or even Rs 22.
It would be best to exit the stock at current levels and consider re-entry only on a close above Rs 45. Subsequent targets are Rs 54, Rs 68 and Rs 82.
Shanthi Gears (Rs 41.3): This stock is moving in a broad trading range between Rs 35 and Rs 60 since May 2009.
The lower boundary of this range is an important trend-decider for the stock and investors can continue to hang on as long as it holds above it. It however needs to be borne in mind that breach of this support can result in the stock plummeting to Rs 29 or even Rs 24.
The stock will face resistance at Rs 47 or Rs 55 over the ensuing weeks and investors with a short investment horizon can exit the stock at either of these levels. Medium-term view will turn positive only on a close above Rs 55. Subsequent targets are Rs 60, Rs 70 and Rs 82.
Please advise on the future of Gateway Distriparks bought at Rs 214.
M.V.N. Rao
Gateway Distriparks (Rs 126): You have purchased Gateway Distriparks close to its 2005 peak at Rs 240.
The stock is in a long-term bear trend over the last six years and it is hard to envisage a move towards this peak just yet.
The stock could, in fact, struggle to move above the strong resistances at Rs 142 and Rs 166. The long-term outlook will turn positive only on a close above the second resistance.
That said Gateway Distriparks has strong support around Rs 95 and below that at Rs 83. Investors can hold the stock as long as it trades above Rs 80.
Continued movement in the range between Rs 100 and Rs 150 will be positive from a medium-term perspective and pave the way for a break-out above Rs 166 over the next couple of years.
What is short-term view for Asian Paints and medium-term view for Lakshmi Vilas Bank?
Vivek and JP
Asian Paints (Rs 2,975.8): In our review of Asian Paints in October last year, we had stressed that the stock was in a strong uptrend. We had also given the target above Rs 3,000 at Rs 3,250. The short-term stop-loss was given at Rs 2,420 while the long-term stop-loss was advised at Rs 1,300.
Though the stock tested our short-term support in February, to record the low at Rs 2,395, it did not sustain there for even two days implying that even the short-term up trend is un-violated.
The stock is currently in a short-term down-trend since the recent peak of Rs 3,230. Short-term supports are at Rs 2,900 and Rs 2,725.
Short-term investors can buy the stock in declines as long as it holds above the second support.
Reversal from either of these levels will see the stock heading higher to Rs 3,427 or Rs 3,570 over the ensuing months. Stop-loss for medium-term investors can be at Rs 2,390.
Lakshmi Vilas Bank (Rs 115.5): The medium-term trend in Lakshmi Vilas Bank is down since the September 2010 peak of Rs 143.
This downtrend is however attempting to halt after retracing half of the up-move from March 2009 low.
Investors need not worry as long as the stock trades above Rs 78. This buttress needs to be breached to denote that the stock is heading downward to the next support zone around Rs 72.
The stock, however, faces key resistance around Rs 120 and inability to rally over this level will result in the stock heading down towards Rs 90 or Rs 78 again.
On the other hand, rally above Rs 120 will lift the stock towards its previous peak of Rs 143.
Kindly let me know the medium-term prospects of Vivimed Labs.
K. Shiva
Vivimed Labs (Rs 282.1): This stock has been extremely volatile since last November.
The down-moves in this stock are however halting above the key medium-term support at Rs 228.
Investors with medium-term perspective can hold the stock as long as it trades above this level. However, decline below this support will drag the stock to Rs 190 or Rs 155 over the medium-term.
Key medium-term resistance is at Rs 315 and then at Rs 350.
Strong break above Rs 350 will propel the stock to Rs 412 over the long-term.

UBS:: Havells India - Philips’ warning to be an overhang

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


UBS Investment Research
Havells India
Philips’ warning to be an overhang
 
„ Philips issues profit warning
Philips has issued a profit warning. It guided for a 530bps decline in the lighting
division’s EBITDA margins, while guiding for low-single-digit growth in lighting
revenue. Philips has blamed the margin compression on difficult conditions in the
European construction market. It has also attributed only 15% of the margin drop
(80bps) to pricing mix.
„ Takeaways for Sylvania
We have already assumed that FY12 EBITDA margins in Sylvania will be 30bps
below the Q4 FY11 level. Europe is only 65% of revenue for Sylvania. While we
anticipate potential downside to our EBITDA margins, we retain our estimate of a
7.6% EBITDA margin.
„ Warning and continued weakness in Europe could be an overhang
While Sylvania only contributes 12.7% to our sum-of-the-parts value for Havells,
we believe the sentimental overhang may continue. Any continued weakness in the
European macro environment could lead to further weakness in the stock, in our
view.
„ Valuation: Buy rating, Rs510 price target
We maintain our Buy rating and price target of Rs510. We derive our price target
from a DCF-based methodology and explicitly forecast long-term valuation drivers
using UBS’s VCAM tool. The stock is trading at 12.5x FY12E PE. We believe this
is very attractive for a high quality business: for FY11-15, we forecast 30%+ ROE
and 20%+ EPS growth. Our price target is 34% above the current level.


Philips profit warning—how to read it
Philips has said that the profit margins will decline from 10.1% in Q111 to 4.8%
in Q211. The margin decline is attributable to:
Q Lower-than-expected capacity utilisation in the lamps division (70% of
margin decline—370bps margin decline);
Q Price mix (15% of margin decline—80bps margin decline);
Q Incremental investment in R&D and margins (15% of margin decline—
80bps margin decline).
We believe that only the price mix related margin decline can be relevant for
Sylvania. However, since Philips’ product  portfolio is far more diverse than
Sylvania’s, it is difficult to draw a direct conclusion for Sylvania.
We spoke to Havells’ management who are confident that Sylvania can maintain
margins within a 750-800bps range and maintain flat revenue in Europe and 10-
15% growth in Latin America. Europe is 67% of Sylvania’s revenue in FY11.
What does this mean for the stock
Havells stock has declined 5.5% post Philips’ warning. Given continued
macroeconomic worries in Europe, we believe there could be continued
weakness in the Havells stock price.


Q Havells India
Havells India (Havells), a leading  Indian electrical consumer durables
manufacturer, is focussed on markets including switchgear, fans, lighting and
fixtures, and cables and wires.  In April 2007, it acquired Sylvania's European,
Latin American, and Asian operations for 227m.  Havells was incorporated in  
1983.
Q Statement of Risk
HVEL is present in market segments that may face increased competition from
competitors, which may hurt our revenue growth as well as margin assumptions.
HVEL derives 30% of its consolidated revenue from Europe. Severe slowdown
in Europe can hurt HVEL consolidated revenue and profits.


Shriram Transport NCD: Invest:: Business Line

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Investors can subscribe to the public issue of Shriram Transport Finance's five-year non-convertible debentures (NCDs). Shriram Transport is one of the leading asset financing NBFCs, which predominantly finances second-hand commercial vehicles.
The interest rate on the NCDs payable annually is 11.6 per cent for an investment of less than Rs 5 lakh. For more than Rs 5 lakh, the coupon rate is 11.35 per cent. The interest rate is attractive compared to prevailing bank deposit rates. Most banks offer rates of 8.75 per cent for this tenure. NCDs will be riskier than bank deposits, which are insured up to Rs 1 lakh. However, this issue is secured by a charge on the company's assets. Instruments of comparable companies in the secondary market offer 10.4 per cent, for credit ratings of AA and AA+.
NCD holders can even trade in these debentures in the secondary market, however, there is liquidity risk for premature encashment as the bond market is relatively illiquid.
The five-year NCD has a put and a call option after 48 months. Put option means that investor has an option to sell the NCD while the call option gives the company the option to repay prematurely. The only shortcoming of this issue is the lack of a cumulative option. This subjects investors in the NCD to the risk of lower rates when they re-invest the interest receipts.
Post-tax yields will be lower given the interest income is taxed at effective tax slab of the investor.
While there is a 3-year option with 11.35 per cent available, the 5-year option is more suitable, given that the coupon rate is high and investors have put option after 4 years.
Shriram Transport has more than Rs 36,000 crore of assets under management and Rs 1,230 crore of net profit for the year ended March 2011. Used commercial vehicles account for three-fourth of assets outstanding.
The company enjoys a AA+ credit rating from CARE and AA rating from Crisil, which signify high investment grade.
The capital adequacy ratio of 24.85 per cent as of March 2011 was comfortable.
The company from time to time has been raising capital to adhere to RBI's new capital adequacy norms. The recent requirement of the RBI to provide additional capital may further strengthen NBFCs, which too is good for NCD holders.
The gross NPA ( non performing assets) and net NPA ratio of Shriram Transport are 2.6 per cent and 0.4 per cent respectively as of March 2011.
The business is highly risky given the concentration on vehicle lending, the cyclical nature of the business and the credit profile of the borrowers. Even as the loans disbursed are secured against the assets, there is credit risk arising from the commercial vehicle financing business being exposed to an economic slowdown and high interest rates.
Tighter regulations (like removing priority status to securitised loans raised by NBFCs) may increase the cost of funds for Shriram Transport, putting pressure on interest costs.
The issue size is Rs 500 crore with an option of retaining an additional subscription of Rs 500 crore. The offer is opening on June 27 and closes on July 9. However, the company has an option of pre-closing the issue if it receives the required subscription

52-week blockbuster: Shree Ganesh Jewellery :: Business Line

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Having gone into a steep slide post its Initial Public Offer in March '10, the stock of gold manufacturer and retailer Shree Ganesh Jewellery House fell to valuations of as low as 3.2 times trailing twelve-month earnings.
However, over the past few months, low valuations coupled with consistent healthy revenue growth and the allure of gold helped the stock chart a recovery. Hitherto an export-focussed company, it stepped up thrust on the more promising domestic market by expansion of its retail chain.
In FY-11, the company expanded its retail chain by 13 stores, with plans to add a further 30 stores in FY-12. Its low debt-equity of 0.5 times was a further plus in light of funding this expansion.
Part of its issue proceeds was earmarked for opening of a gold refinery, the completion of which was recently announced by the company.
This 100-tonne plant is set to be operational by September, which could help expand the thin margins inherent to the gold business.
Shree Ganesh clocked steadily increasing revenue growth over the past four quarters, ending FY-11 with a massive 77 per cent growth. It further managed healthy volumes as well, with a 42 per cent volume growth in FY-11, even as gold prices stayed firmly on their path upward.
Rising raw material costs were offset by controls over other expenses to maintain operating margins at 6.5 per cent in FY-11.

What is driving mid-cap fund performance: Business Line

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Mid-cap funds have always evoked a sense of caution in the minds of investors. These funds are deemed quite volatile and unsuitable for those with an average risk appetite, as they invest predominantly in stocks with less than Rs 7,500 crore market capitalisation. But contrary to the general perception, mid-cap funds have done quite well vis-à-vis their benchmarks over the last 4-5 years.
Consider this: Over the last three years, six out of every 10 mid-cap funds have outperformed indices such as the S&P CNX-500 and BSE Midcap. And the scorecard gets even better over two- and one-year time-frames, with four out of five and two out of three funds outperforming the indices in the said periods.
Interestingly, the number of funds focussed on mid- and small-cap stocks has increased from 27 in 2006 to 45 currently. What's more, returns of mid-cap funds have matched or outperformed CNX Nifty and large-cap funds over one-, two- and three-year periods. For example, over the last three years, the mid-cap fund category average returns, at 8.5 per cent (compounded annually), is better than the large-cap fund universe's average returns by a couple of percentage points. And if a two-year time-frame is taken, at 21.5 percent, the mid-cap funds have beaten both the Nifty and the large-cap funds' average returns by 5-6 percentage points.
However, as a category, the returns of mid-cap funds lagged both Nifty and large-cap funds over longer time-frames of 4-5 years. This dubs their performance relatively plain in comparison with large-cap funds given their riskier mandate and lower returns.
This, however, isn't reason enough to do away with mid-cap funds as some have surprised positively on the returns front. The trick, therefore, is to select the right mid-cap fund and time the investment correctly. Here, we look at the performance of mid-cap funds to find out the best investment bets in their category.

IMPROVING PERFORMANCE

Mid-cap funds are relatively new entrants in the mutual fund industry, with only 27 of them having five-plus years in operations.
But, of these, as many as 10 have performed consistently across market cycles. This means only 10 funds participated well during market upswings and contained downsides reasonably well. If a three-year period is taken, that number goes up to 14.
Some of the funds that delivered over the long term include IDFC Premier Equity, HDFC Mid-cap Opportunities, Sundaram Select Midcap, ICICI Pru Discovery and DSPBR Small and Midcap.
The laggards include: HSBC Mid-cap Opportunities, JM Emerging Leaders, SBI Magnum Midcap, BNP Paribas Midcap and ICICI Pru Emerging STAR.
The difference between the winners and laggards has been determined by how much the NAV of funds fell during 2008-09 and to what extent they were able to participate in the subsequent recovery.
In this regard, some funds saw NAVs plummet 70-86 per cent in 2008-09. So, even a 200 per cent return in the rally that followed was not enough to play catch up — cases in the point being Taurus Discovery, JM Emerging Leaders and BNP Paribas Mid-cap.
But funds such as Canara Robeco Emerging Equities and Magnum SFU Emerging Business did fall heavily, though they recorded more than 260 per cent returns between March 2009 and November 2010.

SECTOR SELECTION, KEY

The best performing funds mentioned earlier had straddled the right sectors across market cycles. For example, the likes of IDFC Premier Equity, HDFC Mid-cap Opportunities and DSPBR Small and Mid-cap made top investments in sectors such as banks, consumer non-durables, pharma, software and auto. These funds invested 10-20 per cent in each of these sectors from 2008 and have more or less maintained prominence to these sectors.
All these sectors, except banks, fell less than the broader markets in 2008 and thus provided some cushion from the market carnage, thanks to their tag of being defensive then. But in the subsequent rally, all these sectors had a phenomenal run and turned out several multi-bagger stocks.
Even in the present volatile markets, many of these sectors continue to hold on, despite higher valuations, as they continue to have relatively sound earnings visibility.
The funds that suffered the most were those that continued to dabble in sectors that were the favourites in the 2007 rally. These included construction, capital goods, textiles and even media and entertainment. These sectors witnessed a battering at the markets, thus dragging down the performance of funds such as HSBC Mid-cap Opportunities, SBI Magnum Midcap, JP Morgan India Smaller Companies and Taurus Discovery. Some funds such as ICICI Pru Emerging STAR also invested over 20 per cent of the portfolio in derivatives during late 2008 which may have dented NAVs.
Another notable aspect was that the outperformers had taken cash positions of anywhere between 10-25 per cent of their portfolios during instances of market volatility.

BEST INVESTMENT BETS

Despite the category failing to beat large-cap funds, there are individual funds that can deliver steady returns.
Funds such as Sundaram Select Mid-cap, ICICI Pru Discovery, Reliance Regular Savings and IDFC Premier Equity, which have five-year track records, have delivered compounded returns of 17-28 per cent, matching that of best large-cap funds.
Others with a 3-4 year track record, such as HDFC Mid-cap Opportunities and DSPBR Small and Midcap too, delivered robust returns, bettering the bellwether indices such as the Sensex and Nifty. Each of these funds has followed one or more of the portfolio moves mentioned earlier to optimise returns, in an adept way in fast changing markets that were 2008-2010.
Investors can choose these funds as a means of diversification and especially take the SIP (systematic investment plan) route to taking exposure for furthering portfolio returns

Banks: Liquidity easing but for wrong reasons:: Credit Suisse

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

● Even as RBI remains in the tightening mode and inflation remains
high (real policy rates are still negative 1.6%), over past few weeks,
3M CP and CD rates are down over 100 bp from their recent peaks.
Yield curve that had inverted is now again moving to upward sloping.
● Deposit growth has picked up (18% YoY) on the back of banks
raising deposit rates by 400 bp+ from their lows. Moreover, liquidity
at banks has improved as loan growth has dropped to 21% (from
24.5%). We expect loan growth to further slow down to 18% levels in
FY12 given the visible drop in retail as well as investment activity.
● Consequently, incremental loan-deposit ratio YTD CY11 has
dropped to 53% from 100%+ in CY10. This will not only depress
incremental blended asset yields (as investment yields
but also limit banks ability to undertake further lending rate increases
to match funding costs rise coming on the back of deposit re-pricing.
● We don’t expect this moderation in short rates to result in any
immediate NIM improvement for financials as it accompanies a drop
in loan growth. HDFC Bank, ICICI remain our preferred sector picks.

Index Outlook: Stocks do an about-turn:: Business Line

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Sensex (18,240.7)
It was a week of high drama with stocks tumbling en masse on Monday ostensibly due to a Government official expressing discontent at the existing double taxation agreement with Mauritius. As if an agreement that has been in existence for 28 years despite the displeasure of the RBI, SEBI and tax authorities can be done away overnight.
The mood was exactly the reverse on Friday as stocks soared in a dizzying manner with traders scrambling to cover short positions and investors in a mad rush to bottom-fish. The Sensex finally ended the week 2 per cent higher. Monsoon and the ongoing troubles in European economies provided the other sidelights.
Volumes that were sedate through the week suddenly flared up on Friday. Value of contracts traded in the derivative segment neared Rs 2,00,000 crore on Friday. Index put call ratio has now fallen below 1 denoting an oversold market towards weekend. Open interest at around Rs 1,45,000 crore too has not attained alarming proportion yet.
In a sudden change of heart, FIIs who were net sellers through June turned buyers in the last two sessions. According to the BSE, they net purchased shares worth Rs 890 crore on Friday alone. Despite this, they have withdrawn Rs 1,800 crore from the secondary market in June.
The Sensex has covered a lot of ground last week, declining to the intra-week low of 17,314 on Monday and then reversing smartly to Friday's peak of 18,269. Oscillators in the daily chart moved deep in to negative zone and then have reversed to move back to the neutral zone in this period. Weekly oscillators are hovering just below the zero line implying a cautious medium-term stance.
We had been reiterating the medium-term targets at 17,420 and 16,647 over the last many weeks in this column. The Sensex declined below the first target on Monday but recovered intra-day to close at 17,507 in that session.
Let us take a look at the long-term picture and then narrow it down to the short-term. A fairly serious long-term correction is currently in progress that is retracing the entire up-move from March 2009 low. Initial retracement targets for this correction are 17,189, 16,758 and 16,118. The index has been attempting to hold above the first support since the beginning of this year. If it manages to do so, it will have bullish long-term connotations though the index can spend the rest of this year in the band between 17,000 and 21,000.
The medium-term trend is down since April. But this appears to be the minor ‘b' of the B wave of the correction that commenced at 21,108. That means we can have an upward moving minor ‘c' that takes the index higher to 18,600 or even 19,811 again. The counts will, however, be modified if the index fails to move beyond 18,300 next week. That will mean that the B wave ended at 19,811 and the C from 21,108 is in motion currently.
So in the short-term, 18,268, Friday's peak is of utmost importance. This level occurs at 38.2 per cent retracement of the down-move from 19,811 (the magic of Fibonacci again!). Failure to close above this level will drag the index down to 17,304 or even 16,720 in the sessions ahead. Conversely, strong move above 18,267 will pave the way for a rally to 18,562 or 18,857. Supports for the week ahead would be at 17,900 and 17,700.
Nifty (5,471.2)
The Nifty too achieved our first medium-term target last Monday. It declined below 5,224 to record the intra-day low of 5,196 before ending the session at 5,257. We needed an emphatic close below 5,224 to signal that it is heading towards the next medium-term target at 4,989. This bounce from the first target means that the worst could have been averted for the time being.
We will, however, need to watch the level of 5,481 very carefully to decide if the short-term trend has reversed higher. Inability to move above this level will mean that the index can move down to 5,196 or even 5,015 in the ensuing weeks.
On the other hand, close above 5,481 will mean that the index is heading higher to 5,570 or 5,658. Those holding short positions should therefore close their positions if the Nifty appears to be moving strongly above this key resistance at 5,481.
The medium-term trend will reverse higher only on a move above 5,658. Such a move will mean that the index can move to the long-term resistance around 5,900 again.
Global Cues
It was worries on the health of Italian banks coupled with slowing economic growth in the US that pegged global equity markets last week. Most European and US markets closed on a negative note after a strong start to the week. DJ Euro STOXX 50 closed around 2 per cent lower.
It is obvious that the medium-term downtrend that began from the May peak continues to hold sway in the European markets.
Greece that has been at the eye of the storm saw its benchmark hit 13-year low last week.
CBOE Volatility index that had spiked up to 25 in the previous week moved slightly lower though it closed the week at 21.
The Dow was volatile around the important support at 12,000 over the past sessions. This index too continues the down-trend that began in May.
A strong close above 12,500 is needed to mitigate the short-term risk in the index. Else it could slide down towards the next downward target at 11,000.
In contrast, most Asian markets closed on a strong note last week, largely helped by a surge towards the weekend. Shanghai Composite and Nikkei reversed after a prolonged downtrend while others such as the Philippines Composite and KLSE (the Malaysian benchmark) resumed their uptrend